Abstract:BACKGROUND & AIMS:Acetaminophen (APAP)-induced liver injury is the most frequent cause of acute liver failure in the US and many other countries. Metabolism of APAP results in formation of APAP protein adducts (APAP-AD) in hepatocytes and triggers mitochondrial dysfunction and necrosis. However, the mechanisms for how APAP-AD are removed from hepatocytes remain unknown.METHODS:Mice or primary hepatocytes were treated with APAP. APAP-AD were determined by immunoblot, immunostaining and high pressure liquid chomatography with electrochemical detection analysis.RESULTS:We found that APAP-AD were detected at 1h, peaked at approximately 2h, declined at 6h and almost full removed at 24h post treatment with APAP in mouse livers and in primary mouse hepatocytes. APAP-AD displayed a punctate pattern and were colocalized with GFP-LC3 positive autophagosomes and Lamp1 positive lysosomes in APAP-treated primary hepatocytes. Moreover, isolated autophagosomes and autolysosomes from APAP-treated mouse livers contained APAP-AD, suggesting autophagy may selectively remove APAP-AD. APAP-AD were detected in both detergent soluble and insoluble pools in APAP-treated mouse livers and hepatocytes. More importantly, pharmacological inhibition of autophagy by leupeptin or chloroquine increased whereas induction of autophagy by Torin 1 decreased serum APAP-AD levels in APAP-treated mice, which correlated with alanine aminotransferase levels and liver necrosis. Furthermore, SQSTM1/p62, an autophagy receptor protein, was recruited to APAP-AD. Adenovirus-mediated shRNA knockdown of SQSTM1/p62 led to increased APAP-AD and necrosis in primary hepatocytes.CONCLUSIONS:Our data indicate that APAP-AD are removed though selective autophagy. Pharmacological induction of autophagy may be a novel promising approach for treating APAP-induced liver injury.LAY SUMMARY:Acetaminophen overdose can form acetaminophen protein adducts and mitochondria damage in hepatocytes resulting in liver injury. Activation of autophagy-lysosomal degradation pathway can help to remove acetaminophen protein adducts. Pharmacological induction of autophagy may be a novel promising approach for treating APAP-induced liver injury.

Autophagy and acetaminophen-induced hepatotoxicity

Role and Mechanisms of Autophagy in Acetaminophen‐induced Liver Injury

Targeting Autophagy for Acetaminophen-Induced Liver Injury: An Update

Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions

Single-cell RNA Sequencing Reveals the Dynamics of Hepatic Non-Parenchymal Cells in Autoprotection Against Acetaminophen-Induced Hepatotoxicity

Inhibiting Hepatocyte Uric Acid Synthesis and Reabsorption Ameliorates Acetaminophen-Induced Acute Liver Injury in Mice.

The Complex Roles of Neutrophils in APAP-induced Liver Injury.

The molecular mechanisms of acetaminophen-induced hepatotoxicity and its potential therapeutic targets

Removal of Acetaminophen Protein Adducts by Autophagy Protects Against Acetaminophen-Induced Liver Injury in Mice.

Molecular Pathogenesis of Acetaminophen-Induced Liver Injury and Its Treatment Options

Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update

Acetaminophen Hepatotoxicity: Paradigm for Understanding Mechanisms of Drug-Induced Liver Injury

Mitophagy protects against acetaminophen-induced acute liver injury in mice through inhibiting NLRP3 inflammasome activation

Targeting autophagy for drug-induced hepatotoxicity

Suppression of glomerular damage and apoptosis and biomarkers of acute kidney injury induced by acetaminophen toxicity using a combination of resveratrol and quercetin

Targeting Innate Immune Responses to Attenuate Acetaminophen-Induced Hepatotoxicity

Phellinus Linteus Polysaccharides Mediates Acetaminophen-Induced Hepatotoxicity Via Activating AMPK/Nrf2 Signaling Pathways.

Recent advance in the role of peroxisome proliferator-activated receptor α in acetaminophen-induced hepatotoxicity

Acetaminophen-induced liver injury: Molecular mechanism and treatments from natural products

Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential

Current Etiological Comprehension and Therapeutic Targets of Acetaminophen-Induced Hepatotoxicity